Related Experiment Videos
Differences in beliefs between patients and pharmaceutical specialists regarding medications
Helena Ramström1, Shanaz Afandi, Katarina Elofsson
1Huddinge Hospital Pharmacy, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. helena.ramstrom@apoteket.se
Objective:
To investigate beliefs concerning medication among patients and pharmaceutical specialists (3 or 5 years of higher education).
Method:
The Beliefs about Medicines Questionnaire (BMQ)-General, which assesses beliefs about medicines in general, was used.
Results:
For the analyses, 141 (response rate 82%) and 136 (response rate 79%) questionnaires from the patients and pharmaceutical specialists, respectively, were included. The results showed a statistical significant difference between patients and pharmaceutical specialists in beliefs about medicines. Whereas the patients expressed a more negative attitude about medicines (stronger beliefs about medicines as being harmful and less favourable) the pharmaceutical specialists expressed the contrary. However, the pharmaceutical specialists had stronger concerns regarding over-use of medicines as compared to the patients.
Conclusion:
Patients and pharmaceutical specialists expressed different views regarding medications. To achieve concordance in the pharmaceutical care process, pharmaceutical specialists need to exchange information about patients' experiences and not take for granted that they share their views regarding medications.
Practice Implications:
The pharmaceutical specialists should elicit the patient's concerns about the prescribed medications and be aware of that non-adherence is often the result of the patients making rational decisions about their treatment.
Related Concept Videos
Dosage Regimen: Individualization
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioequivalence of Drugs: Drugs with Multiple Indications
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence